Friday, March 8, 2024

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

 https://www.journalofinfection.com/article/S0163-4453(24)00064-1/fulltext

No comments: